Residency · Residency · Neurology
Elevated Intracranial Pressure: Recognition and Management
Introduction
Elevated intracranial pressure (ICP) is a neurological emergency that can rapidly lead to brain herniation and death if not recognized and treated promptly. Understanding the physiology of intracranial dynamics and the stepwise approach to ICP management is essential for every neurologist working in acute care settings.
Intracranial Physiology
The Monro-Kellie Doctrine
The cranial vault is a rigid, fixed-volume compartment containing three components: brain parenchyma (approximately 80%), cerebrospinal fluid (approximately 10%), and blood (approximately 10%). An increase in the volume of one component must be compensated by a decrease in another, or ICP will rise. Normal ICP in adults is 7-15 mmHg and in children 3-7 mmHg. Cerebral perfusion pressure (CPP) equals mean arterial pressure (MAP) minus ICP, with the target generally being 60-70 mmHg.
Intracranial Compliance
Initial volume increases are buffered by CSF displacement into the spinal canal and venous blood displacement out of the skull. Once these compensatory mechanisms are exhausted, small additional volume increases cause exponential rises in ICP (the steep portion of the pressure-volume curve). This explains why patients may appear stable and then deteriorate precipitously.
Etiology of Elevated ICP
Causes include mass lesions (intracerebral hemorrhage, epidural hematoma, subdural hematoma, brain tumor, abscess), diffuse brain edema (traumatic brain injury, hepatic encephalopathy, hyponatremia, anoxic injury), hydrocephalus (obstructive or communicating), increased CSF production (choroid plexus papilloma, which is rare), venous outflow obstruction (cerebral venous sinus thrombosis, jugular venous compression), and idiopathic intracranial hypertension (elevated ICP without mass lesion, hydrocephalus, or venous obstruction).
Clinical Recognition
Symptoms
Symptoms include headache (often worse in the morning or with Valsalva maneuvers), nausea and vomiting (often projectile), visual disturbances (transient visual obscurations, diplopia from CN VI palsy), and altered mental status progressing to obtundation and coma.
Signs
Papilledema (bilateral optic disc swelling on fundoscopy) may be absent in acute elevation. The Cushing triad of hypertension, bradycardia, and irregular respirations is a late and ominous sign indicating brainstem compression. CN VI palsy is a false localizing sign from nerve stretch over the petrous apex. Unilateral pupil dilation indicates CN III compression from uncal herniation.
Herniation Syndromes
Subfalcine (cingulate) herniation involves the cingulate gyrus shifting under the falx, potentially compressing the anterior cerebral artery. Uncal (transtentorial) herniation involves the medial temporal lobe herniating through the tentorial notch, producing ipsilateral CN III palsy and contralateral hemiparesis (the Kernohan notch phenomenon can produce ipsilateral hemiparesis as a false localizing sign). Central (downward) herniation produces bilateral diencephalic compression progressing to midbrain, pons, and medulla. Tonsillar herniation involves cerebellar tonsils descending through the foramen magnum, causing cardiorespiratory arrest. Upward (ascending) herniation occurs when a posterior fossa mass pushes the cerebellum upward through the tentorial notch.
ICP Monitoring
The external ventricular drain (EVD) is the gold standard, allowing both measurement and therapeutic CSF drainage. Intraparenchymal monitors (fiberoptic or strain gauge catheters placed into brain tissue) provide accurate measurement but cannot drain CSF. Indications for monitoring include GCS 8 or less with abnormal CT, or GCS 8 or less with normal CT plus two or more of: age over 40, unilateral or bilateral posturing, or SBP less than 90 mmHg. Noninvasive assessments include optic nerve sheath diameter on ultrasound (greater than 5 mm suggests elevated ICP) and transcranial Doppler pulsatility index.
Management
Tiered Approach to ICP Management
| Tier | Interventions | Details |
|---|---|---|
| Tier 0 (General) | HOB elevation, midline head, normothermia, sedation, euvolemia | Target CPP 60-70 mmHg; avoid Na <140 |
| Tier 1 | CSF drainage (EVD), osmotic therapy | Mannitol 0.25-1 g/kg; HTS 23.4% 30 mL or 3% infusion |
| Tier 2 | Neuromuscular blockade, moderate hyperventilation, hypothermia | PaCO2 30-35 mmHg (temporary); TTM 33-35°C |
| Tier 3 | Decompressive craniectomy, barbiturate coma | Pentobarbital to burst suppression; craniectomy for malignant MCA |
General Measures (Tier Zero)
The head of bed should be elevated to 30 degrees. The head and neck should be kept midline to optimize jugular venous outflow. Hyperthermia should be avoided with normothermia targeted. Euvolemia should be maintained while avoiding hypotension (target CPP 60-70 mmHg). Adequate sedation and analgesia reduce metabolic demand and ICP spikes. Hyponatremia should be avoided (maintain serum sodium 140-145 mEq/L or higher).
Tier One Interventions
CSF drainage via EVD provides immediate and effective ICP reduction. Osmotic therapy with mannitol (0.25-1 g/kg IV bolus) or hypertonic saline (23.4% via central line as a 30 mL bolus, or 3% as a continuous infusion) is effective. Serum osmolality should be monitored (hold mannitol if osmolality exceeds 320 mOsm/kg), and serum sodium should be kept below 160 mEq/L with hypertonic saline.
Tier Two Interventions
Neuromuscular blockade reduces ICP spikes from coughing and shivering. Moderate hyperventilation targeting PaCO2 30-35 mmHg produces rapid but transient ICP reduction via cerebral vasoconstriction; prolonged use should be avoided due to rebound vasodilation and ischemia risk. Hypothermia with targeted temperature management to 33-35 degrees C has mixed evidence.
Tier Three Interventions
Decompressive craniectomy (surgical removal of a portion of the skull to allow brain swelling) showed survival benefit in malignant MCA infarction in select patients in the DECIMAL and DESTINY trials. Barbiturate coma with pentobarbital infusion achieves burst suppression on EEG but carries significant hypotension risk.
Clinical Pearls
The Cushing triad is a late finding; treatment for suspected elevated ICP should not wait for it to appear. Mannitol and hypertonic saline are both effective first-line osmotic agents; hypertonic saline may be preferred in hypotensive patients because mannitol causes osmotic diuresis. A unilateral fixed and dilated pupil in the setting of declining consciousness is uncal herniation until proven otherwise and requires emergent intervention. Hyperventilation provides rapid but temporary ICP reduction and should be used as a bridge to definitive treatment, not as sustained therapy. The underlying cause of elevated ICP must always be identified and treated because osmotic therapy and surgical interventions buy time but do not address the root pathology.
References
- Stocchetti N, Maas AIR. Traumatic intracranial hypertension. N Engl J Med. 2014;370(22):2121-2130.
- Hawryluk GWJ, Aguilera S, Buki A, et al. A management algorithm for patients with intracranial pressure monitoring: the Seattle International Severe Traumatic Brain Injury Consensus Conference (SIBICC). Intensive Care Med. 2019;45(12):1783-1794.
- Cook AM, Morgan Jones G, Hawryluk GWJ, et al. Guidelines for the acute treatment of cerebral edema in neurocritical care patients. Neurocrit Care. 2020;32(3):647-666.
- Vahedi K, Hofmeijer J, Juettler E, et al. Early decompressive surgery in malignant infarction of the middle cerebral artery. Lancet Neurol. 2007;6(3):215-222.